Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI DISCOVER 2 Study Meets Primary & Secondary Endpoints Conference Call and Webcast Today at 8:30 A.M. EST to Discuss Results CHICAGO, Feb....
ReShape Medical Completes Enrollment of Pivotal Clinical Trial for Weight Loss Device SAN CLEMENTE, CA – February 25, 2013 – ReShape Medical® Inc announced today that it has completed enrollment in the pivotal clinical trial for the ReShape Duo® Intragastric Balloon,...
AccessClosure, Inc. Launches MynxGrip™ Vascular Closure Device New Grip Technology™ Sealant Redefines Active Closure Mountain View, CA (February 27, 2012) – AccessClosure, Inc., the market leader in extravascular closure devices, announced today the FDA approval and...
Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology BOULDER, Colo. and SOUTH SAN FRANCISCO, Calif., March 5, 2013 /PRNewswire/ — Array BioPharma Inc. (NASDAQ: ARRY) and Global Blood Therapeutics today...
Direct Flow Medical® Transcatheter Aortic Valve System Demonstrates Excellent Six-Month Outcomes In Discover Trial Results Presented on Podium at American College of Cardiology Annual Meeting SAN FRANCISCO, Calif., March 12, 2013 – Direct Flow Medical®, Inc., a...
Recent Comments